These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 14648658)

  • 1. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
    Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ
    J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA
    J Clin Oncol; 2005 Sep; 23(25):5993-6001. PubMed ID: 16135467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
    Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA
    Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.
    Theissig F; Baak JP; Schuurmans L; Haroske G; Meyer W; Kunze KD
    Anal Cell Pathol; 1996 Mar; 10(2):85-99. PubMed ID: 8721952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(5):1701-6. PubMed ID: 1768039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of necrosis in Nigerian breast cancer.
    Ikpatt O; Ndoma-Egba R; Collan Y
    Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cathepsin-D expression in female breast cancer.
    Aaltonen M; Lipponen P; Kosma VM; Aaltomaa S; Syrjänen K
    Anticancer Res; 1995; 15(3):1033-7. PubMed ID: 7645922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of prognostic significance of histological grade in node-negative invasive breast carcinoma.
    Younes M; Laucirica R
    Clin Cancer Res; 1997 Apr; 3(4):601-4. PubMed ID: 9815726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA; Gudlaugsson E;
    Eur J Cancer; 2007 Feb; 43(3):527-35. PubMed ID: 17110097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization.
    Günther K; Merkelbach-Bruse S; Amo-Takyi BK; Handt S; Schröder W; Tietze L
    J Pathol; 2001 Jan; 193(1):40-7. PubMed ID: 11169514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients.
    Ikpatt OF; Ndoma-Egba R
    Cent Afr J Med; 2003; 49(11-12):122-6. PubMed ID: 15301464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.